Future HIV TherapyThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

• Contents
• Discussions

Pages: 1  2  3  

Impact of the global economic crisis on antiretroviral treatment programsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
HIV Therapy , November 2009, Vol. 3, No. 6, Pages 545-548. (Source: Future HIV Therapy)
Source: Future HIV Therapy - October 30, 2009 Category: Infectious Diseases Tags: article Source Type: journals

The K65R mutation in HIV-1 reverse transcriptase: genetic barriers, resistance profile and clinical implicationsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
HIV Therapy , November 2009, Vol. 3, No. 6, Pages 583-594. (Source: Future HIV Therapy)
Source: Future HIV Therapy - October 30, 2009 Category: Infectious Diseases Tags: article Source Type: journals

Antiretroviral therapy in Malaysia: identifying barriers to universal accessEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
HIV Therapy , November 2009, Vol. 3, No. 6, Pages 573-582. (Source: Future HIV Therapy)
Source: Future HIV Therapy - October 30, 2009 Category: Infectious Diseases Tags: article Source Type: journals

HIV infection: just an infectious disease?Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
HIV Therapy , November 2009, Vol. 3, No. 6, Pages 553-555. (Source: Future HIV Therapy)
Source: Future HIV Therapy - October 30, 2009 Category: Infectious Diseases Tags: article Source Type: journals

How sweet it is? Susceptibility to diabetes mellitus in HIV-1 treatmentEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
HIV Therapy , November 2009, Vol. 3, No. 6, Pages 613-624. (Source: Future HIV Therapy)
Source: Future HIV Therapy - October 30, 2009 Category: Infectious Diseases Tags: article Source Type: journals

AcknowledgementsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
HIV Therapy , November 2009, Vol. 3, No. 6, Pages 647-647. (Source: Future HIV Therapy)
Source: Future HIV Therapy - October 30, 2009 Category: Infectious Diseases Tags: article Source Type: journals

Severe acute malnutrition and HIV in African childrenEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
HIV Therapy , November 2009, Vol. 3, No. 6, Pages 595-611. (Source: Future HIV Therapy)
Source: Future HIV Therapy - October 30, 2009 Category: Infectious Diseases Tags: article Source Type: journals

Pharmacokinetics of HIV non-nucleoside reverse-transcriptase inhibitorsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
HIV Therapy , November 2009, Vol. 3, No. 6, Pages 625-632. (Source: Future HIV Therapy)
Source: Future HIV Therapy - October 30, 2009 Category: Infectious Diseases Tags: article Source Type: journals

Secondary structure of the HIV-1 genomeEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
HIV Therapy , November 2009, Vol. 3, No. 6, Pages 557-563. (Source: Future HIV Therapy)
Source: Future HIV Therapy - October 30, 2009 Category: Infectious Diseases Tags: article Source Type: journals

Designing immunity to HIV: manipulating antibody-dependent cellular cytotoxicity antibodiesEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
HIV Therapy , November 2009, Vol. 3, No. 6, Pages 633-640. (Source: Future HIV Therapy)
Source: Future HIV Therapy - October 30, 2009 Category: Infectious Diseases Tags: article Source Type: journals

Vaccination of HIV-infected adultsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
HIV Therapy , November 2009, Vol. 3, No. 6, Pages 565-572. (Source: Future HIV Therapy)
Source: Future HIV Therapy - October 30, 2009 Category: Infectious Diseases Tags: article Source Type: journals

Management of late presentation in HIV: what the data tell usEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
HIV Therapy , September 2009, Vol. 3, No. 5, Pages 423-426. (Source: Future HIV Therapy)
Source: Future HIV Therapy - September 8, 2009 Category: Infectious Diseases Tags: article Source Type: journals

HAART for children with treatment failureEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
HIV Therapy , September 2009, Vol. 3, No. 5, Pages 485-499. (Source: Future HIV Therapy)
Source: Future HIV Therapy - September 8, 2009 Category: Infectious Diseases Tags: article Source Type: journals

Transmitted drug resistance in nonsubtype B HIV-1 infectionEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
HIV Therapy , September 2009, Vol. 3, No. 5, Pages 447-465. (Source: Future HIV Therapy)
Source: Future HIV Therapy - September 8, 2009 Category: Infectious Diseases Tags: article Source Type: journals

HIV-1 nonsubtype B distribution across certain resource-rich countriesEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
HIV Therapy , September 2009, Vol. 3, No. 5, Pages 467-483. (Source: Future HIV Therapy)
Source: Future HIV Therapy - September 8, 2009 Category: Infectious Diseases Tags: article Source Type: journals

AcknowledgementsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
HIV Therapy , September 2009, Vol. 3, No. 5, Pages 543-543. (Source: Future HIV Therapy)
Source: Future HIV Therapy - September 8, 2009 Category: Infectious Diseases Tags: article Source Type: journals

Bulletin BoardEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
HIV Therapy , September 2009, Vol. 3, No. 5, Pages 427-429. (Source: Future HIV Therapy)
Source: Future HIV Therapy - September 8, 2009 Category: Infectious Diseases Tags: article Source Type: journals

Adult combination antiretroviral therapy in sub-Saharan Africa: lessons from Botswana and future challengesEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
HIV Therapy , September 2009, Vol. 3, No. 5, Pages 501-526. (Source: Future HIV Therapy)
Source: Future HIV Therapy - September 8, 2009 Category: Infectious Diseases Tags: article Source Type: journals

Dendritic cell function in HIV infectionEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
HIV Therapy , September 2009, Vol. 3, No. 5, Pages 527-537. (Source: Future HIV Therapy)
Source: Future HIV Therapy - September 8, 2009 Category: Infectious Diseases Tags: article Source Type: journals

Rethinking the role of the local community in HIV epidemic spread in sub-Saharan Africa: a proximate-determinants approachEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
HIV Therapy , September 2009, Vol. 3, No. 5, Pages 435-445. (Source: Future HIV Therapy)
Source: Future HIV Therapy - September 8, 2009 Category: Infectious Diseases Tags: article Source Type: journals

5th European Conference on Clinical and Social Research on AIDS and DrugsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
HIV Therapy , September 2009, Vol. 3, No. 5, Pages 431-433. (Source: Future HIV Therapy)
Source: Future HIV Therapy - September 8, 2009 Category: Infectious Diseases Tags: article Source Type: journals

International and domestic funding for HIV research: how much and how is it spent?Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
HIV Therapy , July 2009, Vol. 3, No. 4, Pages 307-310. (Source: Future HIV Therapy)
Source: Future HIV Therapy - July 6, 2009 Category: Infectious Diseases Tags: article Source Type: journals

Managing HIV infection in infants, children and adolescents with HAARTEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
HIV Therapy , July 2009, Vol. 3, No. 4, Pages 391-404. (Source: Future HIV Therapy)
Source: Future HIV Therapy - July 6, 2009 Category: Infectious Diseases Tags: article Source Type: journals

Future directions in the treatment of HIV–HBV coinfectionEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
HIV Therapy , July 2009, Vol. 3, No. 4, Pages 405-415. (Source: Future HIV Therapy)
Source: Future HIV Therapy - July 6, 2009 Category: Infectious Diseases Tags: article Source Type: journals

Clinical implications of antiretroviral pharmacokinetics and pharmacodynamics in the CNSEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
HIV Therapy , July 2009, Vol. 3, No. 4, Pages 361-367. (Source: Future HIV Therapy)
Source: Future HIV Therapy - July 6, 2009 Category: Infectious Diseases Tags: article Source Type: journals

Future treatment for non-AIDS-defining cancers in HIV-infected patientsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
HIV Therapy , July 2009, Vol. 3, No. 4, Pages 311-314. (Source: Future HIV Therapy)
Source: Future HIV Therapy - July 6, 2009 Category: Infectious Diseases Tags: article Source Type: journals

Managing HIV therapy literacy in resource-limited settingsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
HIV Therapy , July 2009, Vol. 3, No. 4, Pages 339-344. (Source: Future HIV Therapy)
Source: Future HIV Therapy - July 6, 2009 Category: Infectious Diseases Tags: article Source Type: journals

AcknowledgementsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
HIV Therapy , July 2009, Vol. 3, No. 4, Pages 421-421. (Source: Future HIV Therapy)
Source: Future HIV Therapy - July 6, 2009 Category: Infectious Diseases Tags: article Source Type: journals

Tesamorelin: a synthetic growth hormone-releasing factor analog for the treatment of HIV-associated lipodystrophyEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
HIV Therapy , July 2009, Vol. 3, No. 4, Pages 319-327. (Source: Future HIV Therapy)
Source: Future HIV Therapy - July 6, 2009 Category: Infectious Diseases Tags: article Source Type: journals

Advances in HIV care and treatment in resource-poor countriesEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
HIV Therapy , July 2009, Vol. 3, No. 4, Pages 329-338. (Source: Future HIV Therapy)
Source: Future HIV Therapy - July 6, 2009 Category: Infectious Diseases Tags: article Source Type: journals

Monitoring HIV drug resistance in treatment-naive individuals: molecular indicators, epidemiology and clinical implicationsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
HIV Therapy , July 2009, Vol. 3, No. 4, Pages 369-390. (Source: Future HIV Therapy)
Source: Future HIV Therapy - July 6, 2009 Category: Infectious Diseases Tags: article Source Type: journals

Clinical implications of new findings in HIV basic researchEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
HIV Therapy , July 2009, Vol. 3, No. 4, Pages 351-360. (Source: Future HIV Therapy)
Source: Future HIV Therapy - July 6, 2009 Category: Infectious Diseases Tags: article Source Type: journals

Public–private partnerships and HIV vaccine researchEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
HIV Therapy , July 2009, Vol. 3, No. 4, Pages 345-349. (Source: Future HIV Therapy)
Source: Future HIV Therapy - July 6, 2009 Category: Infectious Diseases Tags: article Source Type: journals

Bulletin BoardEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
HIV Therapy , July 2009, Vol. 3, No. 4, Pages 315-317. (Source: Future HIV Therapy)
Source: Future HIV Therapy - April 30, 2009 Category: Infectious Diseases Tags: article Source Type: journals

Are we ready for home-based, self-testing for HIV?Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Future HIV Therapy , November 2008, Vol. 2, No. 6, Pages 515-520. (Source: Future HIV Therapy)
Source: Future HIV Therapy - December 11, 2008 Category: Infectious Diseases Tags: article Source Type: journals

RNAi as a potential new therapy for HIV infectionEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Future HIV Therapy , November 2008, Vol. 2, No. 6, Pages 567-577. Controlling HIV infection continues to be a major clinical and scientific challenge. Despite the therapeutic benefits associated with HAART, the need for novel treatment approaches to combat HIV-1 remains. Effective inhibition of HIV-1 infection has been ... (Source: Future HIV Therapy)
Source: Future HIV Therapy - December 11, 2008 Category: Infectious Diseases Tags: article Source Type: journals

AcknowledgementsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Future HIV Therapy , November 2008, Vol. 2, No. 6, Pages 617-617. (Source: Future HIV Therapy)
Source: Future HIV Therapy - December 11, 2008 Category: Infectious Diseases Tags: article Source Type: journals

Bulletin BoardEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Future HIV Therapy , November 2008, Vol. 2, No. 6, Pages 521-523. (Source: Future HIV Therapy)
Source: Future HIV Therapy - December 11, 2008 Category: Infectious Diseases Tags: article Source Type: journals

Immunology of SIV infection in natural hosts: implications for HIV pathogenesisEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Future HIV Therapy , November 2008, Vol. 2, No. 6, Pages 603-611. AIDS is one of the worst pathologies of our time. Unfortunately, and despite a very large number of studies, the mechanisms of HIV pathogenesis in humans are still poorly understood. Nonpathogenic SIV infection of African nonhuman primates represents a ... (Source: Future HIV Therapy)
Source: Future HIV Therapy - December 11, 2008 Category: Infectious Diseases Tags: article Source Type: journals

Drug resistance differences among HIV types and subtypes: a growing problemEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Future HIV Therapy , November 2008, Vol. 2, No. 6, Pages 579-593. Although HIV-1 subtype B accounts for only 10% of worldwide HIV infections, almost all knowledge regarding antiretroviral (ARV) drug development and viral resistance is based on this subtype. More recently, an increasing body of evidence suggests that ... (Source: Future HIV Therapy)
Source: Future HIV Therapy - December 11, 2008 Category: Infectious Diseases Tags: article Source Type: journals

Etravirine: a second-generation NNRTI for treatment-experienced adults with resistant HIV-1 infectionEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Future HIV Therapy , November 2008, Vol. 2, No. 6, Pages 525-537. Etravirine, a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI), was approved in the USA in January, 2008, with approval in Europe expected later this year. It is dosed at 200 mg (two 100 mg tablets) twice daily foll owing a meal. ... (Source: Future HIV Therapy)
Source: Future HIV Therapy - December 11, 2008 Category: Infectious Diseases Tags: article Source Type: journals

Proposed guidelines for the prevention of mother-to-child transmission of HIV in middle-income countries: the Thai Red Cross PMTCT guidelinesEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Future HIV Therapy , November 2008, Vol. 2, No. 6, Pages 551-565. The rate of perinatal HIV transmission has drastically decreased in high-income countries where interventions to reduce mother-to-child transmission of HIV have been successfully implemented. Guidelines for the prevention of mother-to-child transmission ... (Source: Future HIV Therapy)
Source: Future HIV Therapy - December 11, 2008 Category: Infectious Diseases Tags: article Source Type: journals

Neurosyphilis in HIV-infected patientsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Future HIV Therapy , November 2008, Vol. 2, No. 6, Pages 595-602. Initial syphilis infection results in CNS invasion by the spirochete Treponema pallidum in approximately 25–30% of cases. Spontaneous CNS clearance can occur, and most patients do not develop neurosyphilis. However, neurosyphilis may be more commonly ... (Source: Future HIV Therapy)
Source: Future HIV Therapy - December 11, 2008 Category: Infectious Diseases Tags: article Source Type: journals

Self-reported low physical function is associated with diabetes mellitus and insulin resistance in HIV-positive and HIV-negative menEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Future HIV Therapy , November 2008, Vol. 2, No. 6, Pages 539-549. Aim: To investigate the association between self-reported physical function (as a surrogate for physical activity) and diabetes mellitus (DM) and insulin resistance (IR) among HIV-positive and -negative men. Method: A total of 384 HIV-negative and 274 ... (Source: Future HIV Therapy)
Source: Future HIV Therapy - December 11, 2008 Category: Infectious Diseases Tags: article Source Type: journals

The number of HIV-infected individuals decreases by half in India: impact on the global epidemiology of HIV/AIDSEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Future HIV Therapy , September 2008, Vol. 2, No. 5, Pages 395-398. (Source: Future HIV Therapy)
Source: Future HIV Therapy - September 20, 2008 Category: Infectious Diseases Tags: article Source Type: journals

AcknowledgementsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Future HIV Therapy , September 2008, Vol. 2, No. 5, Pages 513-513. (Source: Future HIV Therapy)
Source: Future HIV Therapy - September 19, 2008 Category: Infectious Diseases Tags: article Source Type: journals

Update on the development of HIV entry inhibitorsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Future HIV Therapy , September 2008, Vol. 2, No. 5, Pages 479-507. HIV fusion and entry are two steps in the viral lifecycle that can be targeted by several classes of antiviral drugs. The discovery of chemokines focused the attention on cellular co-receptors used by the virus for entering cells, and on the various ... (Source: Future HIV Therapy)
Source: Future HIV Therapy - September 19, 2008 Category: Infectious Diseases Tags: article Source Type: journals

Clinical significance of HIV-associated bone loss: when and how to interveneEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Future HIV Therapy , September 2008, Vol. 2, No. 5, Pages 465-478. Moderate decreases in bone mineral density (BMD) occur after initiation of several antiretroviral regimens. However, BMD appears to stabilize over time. Alendronate and zoledronate therapy decreases bone turnover markers and increases BMD in HIV-positive ... (Source: Future HIV Therapy)
Source: Future HIV Therapy - September 19, 2008 Category: Infectious Diseases Tags: article Source Type: journals

Bulletin BoardEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Future HIV Therapy , September 2008, Vol. 2, No. 5, Pages 407-409. (Source: Future HIV Therapy)
Source: Future HIV Therapy - September 19, 2008 Category: Infectious Diseases Tags: article Source Type: journals

Male circumcision is an efficacious, lasting and cost-effective strategy for combating HIV in high-prevalence AIDS epidemicsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Future HIV Therapy , September 2008, Vol. 2, No. 5, Pages 399-405. (Source: Future HIV Therapy)
Source: Future HIV Therapy - September 19, 2008 Category: Infectious Diseases Tags: article Source Type: journals